Psoriatic Arthritis

Clinical specialty setting and geographic region can affect the diagnosis timing of psoriatic arthritis, disease management and disease burden, according to researchers in a Healio Dermatology story comparing diagnoses within dermatology and rheumatology.

In the dermatology setting, researchers found a substantial delay from symptom onset to a psoriatic arthritis diagnosis compared with rheumatology, according to LOOP, a multicenter study across 44 sites in the U.S.

ATLANTA — The use of either non-TNF inhibitor biologics or tofacitinib for chronic inflammatory diseases during pregnancy did not significantly increase risk for serious infections among infants, according to findings presented at the 2019 ACR/ARP Annual Meeting.

ATLANTA — Results of a double-blind, randomized, placebo-controlled trial showed a clear benefit of tofacitinib in controlling disease flares in juvenile idiopathic arthritis, according to a speaker at ACR/ARP 2019.

ATLANTA — A vast majority of patients with a cross-section of rheumatic diseases reported that pain, fatigue and mental health issues were those they would like researchers to track, according to a speaker at ACR/ARP 2019.

The FDA has approved Abrilada, a biosimilar to Humira, making it the fifth biosimilar to the reference drug and 25th biosimilar overall to gain approval in the United States, according to an agency press release.

Researchers from The Ohio State University College of Medicine found links between oral health and fruit consumption to psoriasis severity in the top story from Healio Dermatology last week.

Patients with psoriatic arthritis who also have depression were more likely to be on medications for PsA, had fewer swollen joints and lower disease activity via body surface area but also reported higher RAPID3 scores, according to research presented at the American College of Rheumatology/Association of Rheumatology Professionals Annual Meeting.

Repeat, routine testing for latent tuberculosis infection among patients receiving biologics is both costly and of low clinical value, according to findings presented at the 2019 ACR/ARP Annual Meeting.

ATLANTA — Age at onset of psoriasis determines whether psoriasis or psoriatic arthritis starts first in patients with psoriatic arthritis, according to data from the PsART-international web-based registry presented here.